Literature DB >> 18688015

Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.

Eiichiro Yamamoto1, Nobuaki Tamamaki, Taishi Nakamura, Keiichiro Kataoka, Yoshiko Tokutomi, Yi-Fei Dong, Masaya Fukuda, Shinji Matsuba, Hisao Ogawa, Shokei Kim-Mitsuyama.   

Abstract

BACKGROUND AND
PURPOSE: The precise mechanism of salt-induced brain injury is unclear. We examined the detailed causative role of angiotensin II and NADPH oxidase in salt-accelerated brain injury of stroke-prone spontaneously hypertensive rats (SHRSP).
METHODS: We examined the effect of salt loading on brain reactive oxygen species (ROS), inflammation, and apoptosis in SHRSP. Salt-loaded SHRSP were given vehicle, valsartan (an angiotensin AT1 receptor blocker), or hydralazine to compare their efficacy on brain injury. We also examined the efficacy of apocynin (a NADPH oxidase inhibitor) on brain injury of salt-loaded SHRSP.
RESULTS: Cerebral NADPH oxidase activity and ROS in SHRSP were already increased at 1 week after salt loading followed by the significant increase in ED-1-positive cells and neuronal apoptosis. Thus, cerebral NADPH oxidase activation preceded cerebral inflammation and neuronal apoptosis. Despite comparable hypotensive effects between valsartan and hydralazine in salt-loaded SHRSP, valsartan reduced cerebral NADPH oxidase activity and ROS more than hydralazine being accompanied by more prevention of stroke by valsartan than hydralazine. Valsartan, but not hydralazine, prevented neuronal apoptosis, being associated with the suppression of apoptosis signal-regulating kinase 1 activation by valsartan. Moreover, cerebral inflammation was also prevented by valsartan more than hydralazine, being associated with more suppression of monocyte chemotactic protein-1 and tumor necrosis factor-alpha expressions by valsartan. Thus, angiotensin II was directly involved in salt-induced neuronal NADPH oxidase activation, ROS, apoptosis, and inflammation in SHRSP. Apocynin attenuated the enhancement of ROS, cerebral inflammation, neuronal apoptosis, and apoptosis signal-regulating kinase 1 activation and prevented stroke in salt-loaded SHRSP, indicating the causative role of cerebral NADPH oxidase in salt-induced brain injury.
CONCLUSIONS: We obtained the evidence that excess salt, through ROS produced by angiotensin II-activated NADPH oxidase, caused cerebral neuronal apoptosis and inflammation as well as stroke in SHRSP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688015     DOI: 10.1161/STROKEAHA.108.517284

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

2.  The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke.

Authors:  John S Smeda; Noriko Daneshtalab
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-21       Impact factor: 6.200

Review 3.  High salt intake as a multifaceted cardiovascular disease: new support from cellular and molecular evidence.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Angiotensin II triggers apoptosis via enhancement of NADPH oxidase-dependent oxidative stress in a dopaminergic neuronal cell line.

Authors:  Hong-Rui Zhao; Teng Jiang; You-Yong Tian; Qing Gao; Zhang Li; Yang Pan; Liang Wu; Jie Lu; Ying-Dong Zhang
Journal:  Neurochem Res       Date:  2015-02-11       Impact factor: 3.996

5.  Long non-coding RNA and mRNA analysis of Ang II-induced neuronal dysfunction.

Authors:  Lin-Lin Shao; Yue-Hua Jiang; Ling-Yu Jiang; Chuan-Hua Yang; Ying-Zi Qi
Journal:  Mol Biol Rep       Date:  2019-04-03       Impact factor: 2.316

6.  Neuronal over-expression of ACE2 protects brain from ischemia-induced damage.

Authors:  Ji Chen; Yuhui Zhao; Shuzhen Chen; Jinju Wang; Xiang Xiao; Xiaotang Ma; Madhuri Penchikala; Huijing Xia; Eric Lazartigues; Bin Zhao; Yanfang Chen
Journal:  Neuropharmacology       Date:  2014-01-15       Impact factor: 5.250

7.  Mycophenolate mofetil prevents cerebrovascular injury in stroke-prone spontaneously hypertensive rats.

Authors:  Isha S Dhande; Yaming Zhu; Michael C Braun; M John Hicks; Scott E Wenderfer; Peter A Doris
Journal:  Physiol Genomics       Date:  2016-12-23       Impact factor: 3.107

8.  Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy.

Authors:  Imad Al Ghouleh; Giovanna Frazziano; Andres I Rodriguez; Gábor Csányi; Salony Maniar; Claudette M St Croix; Eric E Kelley; Loreto A Egaña; Gyun Jee Song; Alessandro Bisello; Yong J Lee; Patrick J Pagano
Journal:  Cardiovasc Res       Date:  2012-09-20       Impact factor: 10.787

9.  Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion.

Authors:  Adam P Mecca; Timothy E O'Connor; Michael J Katovich; Colin Sumners
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

Review 10.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.